申请人:Takara Shuzo Co, Ltd.
公开号:EP1232756A1
公开(公告)日:2002-08-21
Remedies or preventives for diseases caused by the binding of agonists (endocrine disruptors, etc.) to the estrogen receptor, characterized by containing, as the active ingredient, antagonists such as catechins (for example, epigallocatechin gallate) having the antagonism to the estrogen receptor agonists.
治疗或预防因激动剂(内分泌干扰素等)与雌激素受体结合而引起的疾病的药物,其特征是含有拮抗剂,如儿茶素(例如表没食子儿茶素没食子酸酯)作为活性成分,具有拮抗雌激素受体激动剂的作用。